Clinical information: crd_961-pfo pms japan, patient id: (b)(6).It was reported that on (b)(6) 2021, a 25mm amplatzer pfo occluder was successfully implanted.There were no reported malfunctions or adverse patient effects after the procedure and the patient was discharged on (b)(6) 2021.On (b)(6) 2022, it was confirmed by notification of the implanted monitor that the patient experienced bradycardia.The patient's family reported that the patient had lost consciousness.The patient was diagnosed with complete atrioventricular block and admitted to the hospital.The implantable monitor was removed, and a permanent pacemaker was placed.The patient recovered and was discharged on(b)(6) 2022.
|
An event of bradycardia, loss of consciousness, complete atrioventricular block and permanent pacemaker implantation was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that the patient's medical history included unstable angina, cerebrovascular accident (cva), family history of cerebral infarction (parent or sibling), hypertension, ex-tobacco user and hyperlipidemia.Based on the information received, the cause of the reported incident could not be conclusively determined.Na.
|